Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin resistance in staphylococci.

Arjun Srinivasan1, James D Dick, Trish M Perl

  • 1Division of Infectious Diseases, Department of Internal Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA. asriniv@jhmi.edu

Clinical Microbiology Reviews
|July 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electronic Clinical Quality Measures of Antibiotic Use in Hospitalized Adults with Uncomplicated Community-acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

A Multinational Trial of Rapid Antimicrobial Susceptibility Testing: Is FASTer Better?

JAMA·2026
Same author

Potential for misclassification of community-acquired respiratory virus infections as healthcare-associated respiratory virus infections at a pediatric healthcare system.

Infection control and hospital epidemiology·2026
Same author

Outbreaks of Emerging and Re-Emerging Infections and Their Management in Healthcare Settings.

Infectious disease clinics of North America·2026
Same author

Projected impact of a pathogen reduction intervention on carbapenem-resistant Enterobacterales bloodstream infections and deaths in the United States.

Infection control and hospital epidemiology·2026
Same author

The Impact of a Nationwide Blood Culture Bottle Shortage in 2024 on Healthcare Facilities in the United States.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same journal

Diagnostic challenges in re-emerging rickettsioses: why current tools fall short.

Clinical microbiology reviews·2026
Same journal

Current progress in developing mRNA-lipid nanoparticle vaccines against human bacterial pathogens.

Clinical microbiology reviews·2026
Same journal

The gut microbiome and colorectal cancer.

Clinical microbiology reviews·2026
Same journal

Influence of fungi on epithelial homeostasis and role in inflammatory diseases.

Clinical microbiology reviews·2026
Same journal

Coxsackievirus A6 on the rise: epidemiology, pathogenicity, evolutionary dynamics, and antiviral strategy.

Clinical microbiology reviews·2026
Same journal

Intravesical therapies for catheter-associated urinary tract infections: current approaches and future directions.

Clinical microbiology reviews·2026
See all related articles

Vancomycin resistance in Staphylococcus aureus and coagulase-negative staphylococci is a growing public health threat. This review details epidemiologic, microbiologic, and clinical aspects of this resistance, aiding understanding and management.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Vancomycin is a critical antibiotic for treating resistant gram-positive infections.
  • Emerging vancomycin resistance in Staphylococcus aureus and coagulase-negative staphylococci presents a significant public health challenge.
  • Current understanding of vancomycin resistance mechanisms and epidemiology remains incomplete.

Purpose of the Study:

  • To comprehensively review the epidemiologic, microbiologic, and clinical characteristics of vancomycin resistance in Staphylococci.
  • To consolidate knowledge on common issues like detection and infection control.
  • To delineate organism-specific aspects including resistance mechanisms and treatment.

Main Methods:

  • Literature review of epidemiologic, microbiologic, and clinical data.

Related Experiment Videos

  • Synthesis of information on common and organism-specific challenges.
  • Discussion of laboratory detection, infection control, risk factors, and management.

    • Main Results:

    • Vancomycin resistance is documented in both coagulase-negative staphylococci and Staphylococcus aureus.
    • Key areas reviewed include definitions, detection methods, and infection control strategies.
    • Specific details on epidemiology, risk factors, resistance mechanisms, and management for each organism type are presented.

    Conclusions:

    • A thorough understanding of vancomycin resistance in Staphylococci is crucial for effective public health strategies.
    • This review provides a consolidated resource for clinicians and researchers.
    • Further research is needed to fully elucidate and combat vancomycin resistance in these pathogens.